FDA approves Endo’s Aveed injection for hypogonadism treatment
Hypogonadism (commonly known as Low-T) is related with a deficiency or absence of the male hormone testosterone. The medicine is indicated to produce serum testosterone levels in the
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
In this collaboration, NeoStem will sponsor research in the laboratory of principal investigator Dr Michael Young, director of the Ocular Regenerative Medicine Institute at Massachusetts Eye and Ear
The loan funds will be used to support Lymphoseek commercialization activities, advance the company’s clinical pipeline, accelerate certain development programs, repay certain of the company’s existing outstanding indebtedness
Debiopharm Research & Manufacturing boasts 35 years of expertise in drug development including chemical synthesis, formulation improvement and manufacturing. Major investments have been made since 2007 to automate